We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

63 hedge funds and large institutions have $259M invested in ProQR Therapeutics in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more call options, than puts

Call options by funds: $877K | Put options by funds: $516K

5% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 21

6% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 16

2% less funds holding

Funds holding: 64 → 63 (-1)

9% less capital invested

Capital invested by funds: $286M → $259M (-$27M)

26.2% less ownership

Funds ownership: 86.28% → 60.08% (-26%)

Holders
63
Holders Change
-1
Holders Change %
-1.56%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
15
Reduced
16
Closed
21
Calls
$877K
Puts
$516K
Net Calls
+$361K
Net Calls Change
-$64K

Top Buyers

Rank Fund Capital Flow
1
Rafferty Asset Management
Rafferty Asset Management
New York
+$3.78M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$3.44M
3
GGHC
Gilder Gagnon Howe & Co
New York
+$3.34M
4
Fidelity International
Fidelity International
Bermuda
+$2.39M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$1.99M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$14M
2
Citigroup
Citigroup
New York
-$11.9M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$10.1M
4
MWNA
Marshall Wace North America
New York
-$4.71M
5
Marshall Wace
Marshall Wace
United Kingdom
-$2.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
FSA
26
Franklin Street Advisors
North Carolina
$674K – – –
State Street
27
State Street
Massachusetts
$494K +$472K +73,273 New
UBS Group
28
UBS Group
Switzerland
$418K -$184K -28,602 -32%
GCP
29
GSA Capital Partners
United Kingdom
$413K +$227K +35,137 +134%
Citadel Advisors
30
Citadel Advisors
Florida
$392K +$192K +29,754 +105%
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$372K +$4.29K +665 +1%
Mitsubishi UFJ Asset Management
32
Mitsubishi UFJ Asset Management
Japan
$313K +$299K +46,369 New
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$289K -$138K -21,399 -33%
BFM
34
Boothbay Fund Management
New York
$259K +$248K +38,408 New
CSS
35
Cubist Systematic Strategies
Connecticut
$254K +$144K +22,339 +146%
Citigroup
36
Citigroup
New York
$230K -$11.9M -1,851,440 -98%
AC
37
Apogem Capital
New York
$216K -$16.9K -2,617 -8%
BlackRock
38
BlackRock
New York
$202K +$181K +28,135 +1,482%
Geode Capital Management
39
Geode Capital Management
Massachusetts
$171K +$37.9K +5,873 +30%
Osaic Holdings
40
Osaic Holdings
Arizona
$142K -$1.51K -235 -1%
PCM
41
Pinz Capital Management
New York
$126K +$121K +18,700 New
Group One Trading
42
Group One Trading
Illinois
$114K +$109K +16,898 New
EH
43
Equitable Holdings
New York
$101K +$96.7K +15,000 New
VF
44
Virtu Financial
New York
$94K +$89.5K +13,883 New
Northern Trust
45
Northern Trust
Illinois
$91K -$28.6K -4,432 -25%
LC
46
Lindbrook Capital
California
$85K +$19.3K +3,000 +31%
Ameriprise
47
Ameriprise
Minnesota
$84K +$80K +12,400 New
Millennium Management
48
Millennium Management
New York
$82K -$159K -24,697 -67%
AG
49
Algert Global
California
$76K – – –
Wells Fargo
50
Wells Fargo
California
$74K – – –
1
2
3 4

PRQR Hedge Fund Activity: Q2 2021 in Review

63 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q2 2021, worth a combined $259M — down 9.4% from $286M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of PRQR and 20 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 15 added.

The largest buyer was Rafferty Asset Management, opening a new position worth an estimated $3.78M. The largest seller was RA Capital Management, exiting entirely with an estimated $14M sold.

  • 63 institutional investors held ProQR Therapeutics (PRQR) as of Q2 2021, down from 64 in Q1 2021.
  • Funds reported $259M of ProQR Therapeutics stock for Q2 2021, down 9.4% quarter-over-quarter.
  • 20 funds opened new ProQR Therapeutics positions in Q2 2021 and 21 closed out, a net change of -1 holder.
  • The largest ProQR Therapeutics buyer in Q2 2021 was Rafferty Asset Management, an estimated $3.78M added.
  • The largest ProQR Therapeutics seller in Q2 2021 was RA Capital Management, an estimated $14M sold.

Based on aggregated 13F filings for Q2 2021.